{"id":2017,"date":"2024-04-11T13:47:17","date_gmt":"2024-04-11T13:47:17","guid":{"rendered":"https:\/\/stoxpo.com\/?p=2017"},"modified":"2024-04-11T13:47:18","modified_gmt":"2024-04-11T13:47:18","slug":"rallybio-collaborates-with-johnson-johnson-to-tackle-rare-disease-fnait","status":"publish","type":"post","link":"https:\/\/stoxpo.com\/index.php\/2024\/04\/11\/rallybio-collaborates-with-johnson-johnson-to-tackle-rare-disease-fnait\/","title":{"rendered":"Rallybio Collaborates with Johnson &amp; Johnson to Tackle Rare Disease FNAIT"},"content":{"rendered":"\n<h4 class=\"wp-block-heading\">Partnership Aims to Develop Therapeutic Solutions for Fetal and Neonatal Alloimmune Thrombocytopenia<\/h4>\n\n\n\n<p class=\"wp-block-paragraph\">Rallybio Corporation (RLYB) has announced a collaboration with Johnson &amp; Johnson to advance therapeutic approaches for reducing the risk of fetal and neonatal alloimmune thrombocytopenia (FNAIT). This collaboration includes a $6.6 million equity investment from Johnson &amp; Johnson Innovation \u2013 JJDC, Inc.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Rallybio&#8217;s focus lies in developing RLYB212, a human monoclonal anti-HPA-1a antibody designed to prevent pregnant individuals from alloimmunizing, thereby mitigating the risk of FNAIT in fetuses and newborns. With plans to initiate a Phase 2 dose confirmation study for RLYB212 in the second half of 2024, Rallybio aims to address the critical need for preventative treatment options in individuals at higher risk of FNAIT.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The collaboration with Johnson &amp; Johnson involves funding to raise awareness of Johnson &amp; Johnson&#8217;s FNAIT clinical program alongside Rallybio&#8217;s ongoing natural history study. Together, the companies aspire to drive awareness, screening, and therapeutic advancements to combat FNAIT, ultimately improving outcomes for affected individuals.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Read original press release:<a href=\"https:\/\/www.businesswire.com\/news\/home\/20240408380440\/en\/\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-vivid-cyan-blue-color\">here<\/mark><\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">You might like this article:<a href=\"https:\/\/stoxpo.com\/index.php\/2024\/04\/11\/vertex-pharmaceuticals-to-acquire-alpine-immune-sciences-in-4-9-billion-deal\/\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-vivid-cyan-blue-color\">Vertex Pharmaceuticals to Acquire Alpine Immune Sciences in $4.9 Billion Deal<\/mark><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Partnership Aims to Develop Therapeutic Solutions for Fetal and Neonatal Alloimmune Thrombocytopenia Rallybio Corporation (RLYB) has announced a collaboration with Johnson &amp; Johnson to advance therapeutic approaches for reducing the risk of fetal and neonatal alloimmune thrombocytopenia (FNAIT). This collaboration includes a $6.6 million equity investment from Johnson &amp; Johnson Innovation \u2013 JJDC, Inc. Rallybio&#8217;s [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":1430,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"jnews-multi-image_gallery":[],"jnews_single_post":{"subtitle":"","format":"standard","video":"","gallery":"","source_name":"","source_url":"","via_name":"","via_url":"","override_template":"0","override":[{"template":"8","single_blog_custom":"","parallax":"1","fullscreen":"1","layout":"right-sidebar-narrow","sidebar":"author","second_sidebar":"single-right","sticky_sidebar":"1","share_position":"top","share_float_style":"share-monocrhome","show_share_counter":"0","show_view_counter":"0","show_featured":"1","show_post_meta":"1","show_post_author":"1","show_post_author_image":"1","show_post_date":"1","post_date_format":"default","post_date_format_custom":"Y\/m\/d","show_post_category":"1","show_post_reading_time":"1","post_reading_time_wpm":"300","show_zoom_button":"0","zoom_button_out_step":"2","zoom_button_in_step":"3","show_post_tag":"1","show_prev_next_post":"1","show_popup_post":"1","number_popup_post":"1","show_author_box":"1","show_post_related":"1","show_inline_post_related":"0"}],"override_image_size":"0","image_override":[{"single_post_thumbnail_size":"crop-500","single_post_gallery_size":"crop-500"}],"trending_post":"0","trending_post_position":"meta","trending_post_label":"Trending","sponsored_post":"0","sponsored_post_label":"Sponsored by","sponsored_post_name":"","sponsored_post_url":"","sponsored_post_logo_enable":"0","sponsored_post_logo":"","sponsored_post_desc":"","disable_ad":"0"},"jnews_primary_category":{"id":"","hide":""},"jnews_social_meta":{"fb_title":"","fb_description":"","fb_image":"","twitter_title":"","twitter_description":"","twitter_image":""},"jnews_override_counter":{"override_view_counter":"0","view_counter_number":"0","override_share_counter":"0","share_counter_number":"0","override_like_counter":"0","like_counter_number":"0","override_dislike_counter":"0","dislike_counter_number":"0"},"jnews_post_split":{"enable_post_split":"0","post_split":[{"template":"1","tag":"h2","numbering":"asc","mode":"normal","first":"0","enable_toc":"0","toc_type":"normal"}]},"footnotes":""},"categories":[308,359],"tags":[],"coauthors":[453],"class_list":["post-2017","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-biotechnology","category-small-cap"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Rallybio Collaborates with Johnson &amp; Johnson to Tackle Rare Disease FNAIT - Stoxpo<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/stoxpo.com\/index.php\/2024\/04\/11\/rallybio-collaborates-with-johnson-johnson-to-tackle-rare-disease-fnait\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Rallybio Collaborates with Johnson &amp; Johnson to Tackle Rare Disease FNAIT - Stoxpo\" \/>\n<meta property=\"og:description\" content=\"Partnership Aims to Develop Therapeutic Solutions for Fetal and Neonatal Alloimmune Thrombocytopenia Rallybio Corporation (RLYB) has announced a collaboration with Johnson &amp; Johnson to advance therapeutic approaches for reducing the risk of fetal and neonatal alloimmune thrombocytopenia (FNAIT). This collaboration includes a $6.6 million equity investment from Johnson &amp; Johnson Innovation \u2013 JJDC, Inc. Rallybio&#8217;s [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/stoxpo.com\/index.php\/2024\/04\/11\/rallybio-collaborates-with-johnson-johnson-to-tackle-rare-disease-fnait\/\" \/>\n<meta property=\"og:site_name\" content=\"Stoxpo\" \/>\n<meta property=\"article:published_time\" content=\"2024-04-11T13:47:17+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-04-11T13:47:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/pexels-polina-tankilevitch-3735709-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1706\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Liliana Vida\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Liliana Vida\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/04\\\/11\\\/rallybio-collaborates-with-johnson-johnson-to-tackle-rare-disease-fnait\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/04\\\/11\\\/rallybio-collaborates-with-johnson-johnson-to-tackle-rare-disease-fnait\\\/\"},\"author\":{\"name\":\"Liliana Vida\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#\\\/schema\\\/person\\\/db8b371dfcaa698eaedb5afa5e713fb1\"},\"headline\":\"Rallybio Collaborates with Johnson &amp; Johnson to Tackle Rare Disease FNAIT\",\"datePublished\":\"2024-04-11T13:47:17+00:00\",\"dateModified\":\"2024-04-11T13:47:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/04\\\/11\\\/rallybio-collaborates-with-johnson-johnson-to-tackle-rare-disease-fnait\\\/\"},\"wordCount\":193,\"publisher\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/04\\\/11\\\/rallybio-collaborates-with-johnson-johnson-to-tackle-rare-disease-fnait\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/pexels-polina-tankilevitch-3735709-scaled.jpg\",\"articleSection\":[\"Biotechnology\",\"Small-Cap\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/04\\\/11\\\/rallybio-collaborates-with-johnson-johnson-to-tackle-rare-disease-fnait\\\/\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/04\\\/11\\\/rallybio-collaborates-with-johnson-johnson-to-tackle-rare-disease-fnait\\\/\",\"name\":\"Rallybio Collaborates with Johnson &amp; Johnson to Tackle Rare Disease FNAIT - Stoxpo\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/04\\\/11\\\/rallybio-collaborates-with-johnson-johnson-to-tackle-rare-disease-fnait\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/04\\\/11\\\/rallybio-collaborates-with-johnson-johnson-to-tackle-rare-disease-fnait\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/pexels-polina-tankilevitch-3735709-scaled.jpg\",\"datePublished\":\"2024-04-11T13:47:17+00:00\",\"dateModified\":\"2024-04-11T13:47:18+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/04\\\/11\\\/rallybio-collaborates-with-johnson-johnson-to-tackle-rare-disease-fnait\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/04\\\/11\\\/rallybio-collaborates-with-johnson-johnson-to-tackle-rare-disease-fnait\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/04\\\/11\\\/rallybio-collaborates-with-johnson-johnson-to-tackle-rare-disease-fnait\\\/#primaryimage\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/pexels-polina-tankilevitch-3735709-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/pexels-polina-tankilevitch-3735709-scaled.jpg\",\"width\":2560,\"height\":1706,\"caption\":\"chemistry\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/04\\\/11\\\/rallybio-collaborates-with-johnson-johnson-to-tackle-rare-disease-fnait\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/stoxpo.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Rallybio Collaborates with Johnson &amp; Johnson to Tackle Rare Disease FNAIT\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#website\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/\",\"name\":\"Stoxpo\",\"description\":\"Stock Market &amp; Financial News\",\"publisher\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/stoxpo.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#organization\",\"name\":\"Stoxpo\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/4q4p91-LogoMakr.png\",\"contentUrl\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/4q4p91-LogoMakr.png\",\"width\":250,\"height\":250,\"caption\":\"Stoxpo\"},\"image\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#\\\/schema\\\/person\\\/db8b371dfcaa698eaedb5afa5e713fb1\",\"name\":\"Liliana Vida\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/68bef66f029f68660c9d513c7abee60cc2c1cc99a1c80c13e95592bed4296cfd?s=96&d=mm&r=ga2a6b2037962b89d9d0225f04f06bac6\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/68bef66f029f68660c9d513c7abee60cc2c1cc99a1c80c13e95592bed4296cfd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/68bef66f029f68660c9d513c7abee60cc2c1cc99a1c80c13e95592bed4296cfd?s=96&d=mm&r=g\",\"caption\":\"Liliana Vida\"},\"description\":\"Liliana is a seasoned financial journalist with enthusiasm for unraveling the complexities of market fluctuations and identifying paradigm-shifting trends within the stock market landscape. With years of experience in covering the stock market and publicly traded companies, Liliana has honed her skills in turning press releases into concise, informative articles. For tips and inquiries, reach out to Liliana at tips@stoxpo.com.\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/author\\\/stoxpo-com\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Rallybio Collaborates with Johnson &amp; Johnson to Tackle Rare Disease FNAIT - Stoxpo","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/stoxpo.com\/index.php\/2024\/04\/11\/rallybio-collaborates-with-johnson-johnson-to-tackle-rare-disease-fnait\/","og_locale":"en_US","og_type":"article","og_title":"Rallybio Collaborates with Johnson &amp; Johnson to Tackle Rare Disease FNAIT - Stoxpo","og_description":"Partnership Aims to Develop Therapeutic Solutions for Fetal and Neonatal Alloimmune Thrombocytopenia Rallybio Corporation (RLYB) has announced a collaboration with Johnson &amp; Johnson to advance therapeutic approaches for reducing the risk of fetal and neonatal alloimmune thrombocytopenia (FNAIT). This collaboration includes a $6.6 million equity investment from Johnson &amp; Johnson Innovation \u2013 JJDC, Inc. Rallybio&#8217;s [&hellip;]","og_url":"https:\/\/stoxpo.com\/index.php\/2024\/04\/11\/rallybio-collaborates-with-johnson-johnson-to-tackle-rare-disease-fnait\/","og_site_name":"Stoxpo","article_published_time":"2024-04-11T13:47:17+00:00","article_modified_time":"2024-04-11T13:47:18+00:00","og_image":[{"width":2560,"height":1706,"url":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/pexels-polina-tankilevitch-3735709-scaled.jpg","type":"image\/jpeg"}],"author":"Liliana Vida","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Liliana Vida","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/stoxpo.com\/index.php\/2024\/04\/11\/rallybio-collaborates-with-johnson-johnson-to-tackle-rare-disease-fnait\/#article","isPartOf":{"@id":"https:\/\/stoxpo.com\/index.php\/2024\/04\/11\/rallybio-collaborates-with-johnson-johnson-to-tackle-rare-disease-fnait\/"},"author":{"name":"Liliana Vida","@id":"https:\/\/stoxpo.com\/#\/schema\/person\/db8b371dfcaa698eaedb5afa5e713fb1"},"headline":"Rallybio Collaborates with Johnson &amp; Johnson to Tackle Rare Disease FNAIT","datePublished":"2024-04-11T13:47:17+00:00","dateModified":"2024-04-11T13:47:18+00:00","mainEntityOfPage":{"@id":"https:\/\/stoxpo.com\/index.php\/2024\/04\/11\/rallybio-collaborates-with-johnson-johnson-to-tackle-rare-disease-fnait\/"},"wordCount":193,"publisher":{"@id":"https:\/\/stoxpo.com\/#organization"},"image":{"@id":"https:\/\/stoxpo.com\/index.php\/2024\/04\/11\/rallybio-collaborates-with-johnson-johnson-to-tackle-rare-disease-fnait\/#primaryimage"},"thumbnailUrl":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/pexels-polina-tankilevitch-3735709-scaled.jpg","articleSection":["Biotechnology","Small-Cap"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/stoxpo.com\/index.php\/2024\/04\/11\/rallybio-collaborates-with-johnson-johnson-to-tackle-rare-disease-fnait\/","url":"https:\/\/stoxpo.com\/index.php\/2024\/04\/11\/rallybio-collaborates-with-johnson-johnson-to-tackle-rare-disease-fnait\/","name":"Rallybio Collaborates with Johnson &amp; Johnson to Tackle Rare Disease FNAIT - Stoxpo","isPartOf":{"@id":"https:\/\/stoxpo.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/stoxpo.com\/index.php\/2024\/04\/11\/rallybio-collaborates-with-johnson-johnson-to-tackle-rare-disease-fnait\/#primaryimage"},"image":{"@id":"https:\/\/stoxpo.com\/index.php\/2024\/04\/11\/rallybio-collaborates-with-johnson-johnson-to-tackle-rare-disease-fnait\/#primaryimage"},"thumbnailUrl":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/pexels-polina-tankilevitch-3735709-scaled.jpg","datePublished":"2024-04-11T13:47:17+00:00","dateModified":"2024-04-11T13:47:18+00:00","breadcrumb":{"@id":"https:\/\/stoxpo.com\/index.php\/2024\/04\/11\/rallybio-collaborates-with-johnson-johnson-to-tackle-rare-disease-fnait\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/stoxpo.com\/index.php\/2024\/04\/11\/rallybio-collaborates-with-johnson-johnson-to-tackle-rare-disease-fnait\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/stoxpo.com\/index.php\/2024\/04\/11\/rallybio-collaborates-with-johnson-johnson-to-tackle-rare-disease-fnait\/#primaryimage","url":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/pexels-polina-tankilevitch-3735709-scaled.jpg","contentUrl":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/pexels-polina-tankilevitch-3735709-scaled.jpg","width":2560,"height":1706,"caption":"chemistry"},{"@type":"BreadcrumbList","@id":"https:\/\/stoxpo.com\/index.php\/2024\/04\/11\/rallybio-collaborates-with-johnson-johnson-to-tackle-rare-disease-fnait\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/stoxpo.com\/"},{"@type":"ListItem","position":2,"name":"Rallybio Collaborates with Johnson &amp; Johnson to Tackle Rare Disease FNAIT"}]},{"@type":"WebSite","@id":"https:\/\/stoxpo.com\/#website","url":"https:\/\/stoxpo.com\/","name":"Stoxpo","description":"Stock Market &amp; Financial News","publisher":{"@id":"https:\/\/stoxpo.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/stoxpo.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/stoxpo.com\/#organization","name":"Stoxpo","url":"https:\/\/stoxpo.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/stoxpo.com\/#\/schema\/logo\/image\/","url":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/4q4p91-LogoMakr.png","contentUrl":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/4q4p91-LogoMakr.png","width":250,"height":250,"caption":"Stoxpo"},"image":{"@id":"https:\/\/stoxpo.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/stoxpo.com\/#\/schema\/person\/db8b371dfcaa698eaedb5afa5e713fb1","name":"Liliana Vida","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/68bef66f029f68660c9d513c7abee60cc2c1cc99a1c80c13e95592bed4296cfd?s=96&d=mm&r=ga2a6b2037962b89d9d0225f04f06bac6","url":"https:\/\/secure.gravatar.com\/avatar\/68bef66f029f68660c9d513c7abee60cc2c1cc99a1c80c13e95592bed4296cfd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/68bef66f029f68660c9d513c7abee60cc2c1cc99a1c80c13e95592bed4296cfd?s=96&d=mm&r=g","caption":"Liliana Vida"},"description":"Liliana is a seasoned financial journalist with enthusiasm for unraveling the complexities of market fluctuations and identifying paradigm-shifting trends within the stock market landscape. With years of experience in covering the stock market and publicly traded companies, Liliana has honed her skills in turning press releases into concise, informative articles. For tips and inquiries, reach out to Liliana at tips@stoxpo.com.","url":"https:\/\/stoxpo.com\/index.php\/author\/stoxpo-com\/"}]}},"_links":{"self":[{"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/posts\/2017","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/comments?post=2017"}],"version-history":[{"count":1,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/posts\/2017\/revisions"}],"predecessor-version":[{"id":2018,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/posts\/2017\/revisions\/2018"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/media\/1430"}],"wp:attachment":[{"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/media?parent=2017"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/categories?post=2017"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/tags?post=2017"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/coauthors?post=2017"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}